Literature DB >> 23128017

Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads.

Raed H Abdelhadi1, Samir F Saba, Christopher R Ellis, Pamela K Mason, Daniel B Kramer, Paul A Friedman, Melanie T Gura, John P DiMarco, Andrew S Mugglin, Matthew R Reynolds, Raveen R Bazaz, Linda Kallinen Retel, David L Hayes, Robert G Hauser.   

Abstract

BACKGROUND: Riata and Riata ST leads (St Jude Medical, Sylmar, CA) are prone to failure. There are no independent multicenter reports regarding Riata or Riata ST lead performance.
OBJECTIVE: To conduct a retrospective multicenter study of Riata and Riata ST leads that were implanted and followed at 7 centers.
METHODS: The study included adults who received St Jude Medical Riata or Riata ST leads. Data for Quattro Secure leads were obtained from an earlier study.
RESULTS: From 2002 to 2010, 1081 patients received a Riata (n = 774) or Riata ST (n = 307) lead. Follow-up was longer for Riata than Riata ST leads (4.2 ± 2.4 years vs 3.3 ± 1.7 years; P<.0001). During the study, 67 leads failed (6.2%), including 62 of 774 Riata (8.0%) and 5 of 307 Riata ST (1.6%) leads. Forty-seven of 67 lead failures (70.1%) were caused by electrical malfunction, and 20 lead failures (29.9%) were due to externalized conductors (ECs) that were electrically intact. Of 110 leads examined fluoroscopically, ECs were found in 26 of 81 Riata (32%) and 1 of 29 Riata ST (3.4%) leads. Of 26 Riata leads with ECs, 7 (27%) were malfunctioning. Riata leads had lower overall and malfunction free survival compared to Quattro leads (P<.0001), while Riata ST lead survival was not different (P = .422).
CONCLUSIONS: The survival of Riata (but not Riata ST) leads was lower than Quattro leads; however, Riata ST leads had significantly shorter follow-up than Riata leads. ECs were common in Riata leads, and more than a quarter of Riata leads that had ECs were malfunctioning. Our observations suggest that systematic fluoroscopic examination of patients with Riata leads is appropriate.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23128017     DOI: 10.1016/j.hrthm.2012.10.045

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

1.  Longitudinal follow-up of Riata leads reveals high annual incidence of new conductor externalization and electrical failure.

Authors:  Christian Steinberg; Jean-François Sarrazin; François Philippon; Jean Champagne; Marc-André Bouchard; Franck Molin; Isabelle Nault; Louis Blier; Gilles O'Hara
Journal:  J Interv Card Electrophysiol       Date:  2014-11-16       Impact factor: 1.900

2.  [Lead survival and complications (except infections). Are we doing better nowadays?].

Authors:  Martin Seifert; Michael Neuss; Maren Schöpp; Cornel Koban; Christian Butter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-08-06

3.  Cost of a recall of a single-center experience managing the Riata defibrillator lead.

Authors:  Sarah Hussain; Liza Moorman; J Randall Moorman; John P DiMarco; Rohit Malhotra; Andrew Darby; Kenneth Bilchick; J Michael Mangrum; John D Ferguson; Pamela K Mason
Journal:  Am J Cardiol       Date:  2014-10-30       Impact factor: 2.778

4.  Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance.

Authors:  Daniel B Kramer; Laura A Hatfield; Deepa McGriff; Christopher R Ellis; Melanie T Gura; Michelle Samuel; Linda Kallinen Retel; Robert G Hauser
Journal:  J Am Heart Assoc       Date:  2015-05-29       Impact factor: 5.501

5.  Managing patients with advisory defibrillator leads: what can we learn from published data?

Authors:  F A Bracke; B M van Gelder
Journal:  Neth Heart J       Date:  2015-04       Impact factor: 2.380

Review 6.  Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.

Authors:  Rui Providência; Daniel B Kramer; Dominic Pimenta; Girish G Babu; Laura A Hatfield; Adam Ioannou; Jan Novak; Robert G Hauser; Pier D Lambiase
Journal:  J Am Heart Assoc       Date:  2015-10-30       Impact factor: 5.501

7.  Shock-induced right ventricular pacing failure caused by a short circuit: Uncommon but life-threatening complication of the Riata lead.

Authors:  Itsuro Morishima; Hiroshi Nakajima; Hideyuki Tsuboi; Yumiko Yokoyama; Kazuhiro Naito; Takahito Sone
Journal:  HeartRhythm Case Rep       Date:  2015-02-18

8.  Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database.

Authors:  James P Hummel; Robert J Leipold; Stacey L Amorosi; Haikun Bao; Kristen A Deger; Paul W Jones; Anuraag R Kansal; Lesli S Ott; Sean Stern; Kenneth Stein; Jeptha P Curtis; Joseph G Akar
Journal:  J Cardiovasc Electrophysiol       Date:  2019-04-29

Review 9.  Knowledge Update on the Economic Evaluation of Pacemaker Telemonitoring Systems.

Authors:  Antonio Lopez-Villegas; César Leal-Costa; Mercedes Perez-Heredia; Irene Villegas-Tripiana; Daniel Catalán-Matamoros
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 3.390

10.  Riata silicone defibrillation lead with normal electrical measures at routine ambulatory check: The role of high-voltage shock testing.

Authors:  Elia De Maria; Ambra Borghi; Lorenzo Bonetti; Pier Luigi Fontana; Stefano Cappelli
Journal:  World J Cardiol       Date:  2016-11-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.